News MaaT Pharma

Medisite

05 Septembre 2018
Cancer : la transplantation fécale pourrait aider à mieux supporter la chimiothérapie.

See More

France Inter

4 septembre 2018
La greffe fécale pour redonner des forces aux malades du cancer.

See More

Europe 1

29 Janvier 2018
Label entreprise du jour : "MaaT Pharma"

See more

France 3

29 Mars 2017
Chronique Santé : Essai clinique sur la flore intestinale aux hôpitaux sud de Lyon.

See More

Le Magasine Santé

16 Février 2017
L'autogreffe fécale pour restaurer sa flore intestinale.

See More

Press Releases

MaaT Pharma Launches European Clinical Trial in Severe Acute Graft-versus-Host Disease for patients receiving allogeneic Hematopoietic Stem Cell Transplantation

See More

Press Releases

MaaT Pharma To Release First in Patients Data At The 2017 ASH Meeting On Autologous Fecal Microbiota Transfer And Restoration Of Microbiota Diversity

See More

Press Releases

MaaT Pharma completes patient recruitment of its Odyssée clinical trial.

See More - EN VersionSee More - FR Version

Press Releases

MaaT Pharma announces CE marking for its globally unique medical device.

See More

Press Releases

A major step in the restoration of Gut Microbiota: MaaT Pharma and Biocodex to industrialize FMT & develop an oral formulation.

See More

Press Releases

MaaT Pharma and Lutech Sign Licensing Agreement on Microbiome Therapy for Graft-vs-Host Disease.

See More

Press Releases

MaaT Pharma Presents Product Analysis of its First-in-class High Diversity Microbiome Therapeutic at 2018 EMBO Symposium on The Human Microbiome.

See More

Posters - EMBL

18 septembre 2018

See More

Posters - ECCMID

27 avril 2018

See More

Posters - ASH

10 décembre 2017

See More